Camel colostrum immunotherapy (MERS-CoV seropositive camel colostrum)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Camel colostrum immunotherapy (MERS-CoV seropositive camel colostrum), covering 2025-03-04 to 2025-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial. [Phase 1, Phase 2]